logo
Select company
Select metric
$ 0Capital Expenditure
VS
Market
86
Sector
77
Industry
68
History
87
$ 21.1Close
$ 11.72 - $ 41 52-Week Range
Ticker Information

Ticker

TIL

Company Name

INSTIL BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INSTIL BIO INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TIL - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 58K
6/30/2024$ 5.22M
3/31/2024$ 12.2M
12/31/2023$ 20.66M
9/30/2023$ 33.62M
6/30/2023$ 53.66M
3/31/2023$ 72.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSTIL BIO INC's latest trailing twelve months (TTM) CapEx stands at $ 50.82M.
  • Over the past 5 years, INSTIL BIO INC's average CapEx has been $ 39.81M.
  • The median CapEx for INSTIL BIO INC during this period was $ 42.22M
  • INSTIL BIO INC reached its highest CapEx over the past 5 years at $ 90.04M.
  • The lowest CapEx recorded by INSTIL BIO INC in the same timeframe $ 0

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

TIL - Capital Expenditure, Last 5 years

$ 0

Minimum

Dec 31, 2024

$ 90.04M

Maximum

Sep 30, 2022

$ 39.81M

Average

$ 42.22M

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M